… Extracorporeal photopheresis for the treatment of 34 patients … Extracorporeal photopheresis
permits steroid withdrawal in … Extracorporeal photopheresis in the treatment of chronic graft …

… Of 9 patients with steroid-dependent Crohn disease, 4 were able to be withdrawn from
steroid treatment during extracorporeal photopheresis (ECP) (data shown for these 4 patients). …

Background After the first investigational study on the use of extracorporeal photopheresis
for the treatment of cutaneous T‐cell lymphoma was published in 1983 with its subsequent …

… Extracorporeal photopheresis (ECP) has been in clinical use for over three decades after
receiving FDA approval for the palliative treatment of the Sézary Syndrome variant of …

… Following the first investigational study on the use of extracorporeal photopheresis for the
treatment of cutaneous T-cell lymphoma published in 1983, this technology has received …

… 9 Scarisbrick JJ, Taylor P, Holtick U, Makar Y, Douglas K, Berlin G, Juvonen E, Marshall S:
UK consensus statement on the use of extracorporeal photopheresis for treatment of …

… However, there is no established standard treatment for steroid‐refractory aGvHD.
Extracorporeal photopheresis (ECP) is a type of immunomodulatory method amongst different …

… treatment intensity and response assessment in acute graft-vs-host disease. A sequence
refers to two extracorporeal photopheresis treatment … ; ECP, extracorporeal photopheresis; NC, …

… Following the first investigational study on the use of extracorporeal photopheresis for the
treatment of cutaneous T-cell lymphoma published in 1983, this technology has received …

… Extracorporeal photopheresis (ECP) is a therapeutic technique that combines leukapheresis
and ultraviolet (UV)A irradiation of the leukapheresate after 8-methoxypsoralen treatment …